Outcomes associated with remote, centralized ex vivo lung perfusion (rc-EVLP) for donor lungs in a real-world setting.

There was a nonsignificant trend for decreased glucose use at 2 hours (8.6 mg/dL [IQR, 7.9-9.2 mg/dL] vs 7.8 mg/dL [IQR, 5.3-8.1 mg/dL], P = .05) and decreased lactate production at 2 hours (3.8 mg/dL [IQR, 3.2-5.5 mg/dL] vs 6.0 mg/dL [IQR, 4.3-8.2 mg/dL], P = .05) being predictive of acceptance of DCD lungs after rc-EVLP assessment.

also in 5,406 other papers